Xconomy’s Digital Events →
September 24, 2020 · Boston
October 1, 2020 · Seattle
November 17, 2020 · New York
Cambridge, MA-based Synlogic is using synthetic biology to make tuneable bacteria to treat disease
Sponsored · Whitepaper
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Leveraging technology & expertise to ensure a continual journey from trials to treatments
© 2007-2020, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.